CAMK2G and diabetes mellitus: By targeting overactive CaMKII or its downstream signalling pathways, much of the aberrant cardiovascular effects of the enzyme may be attenuated, substantially improving cardiovascular health, and minimizing the overt mortality from CVD seen in DM patients.